NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission, Genomic Health reported a $3.2 million realized gain in 2016 from a sale of equity securities in connection with the sale of a portion of its Invitae stock holdings. The company further sold all its remaining shares in Invitae in January 2017 for $10.2 million, resulting in a realized gain of $2.8 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.